NCT07266597Not yet recruiting
Micropulse Laser Photocoagulation in Diabetic Macular Edema
Micropulse Laser Photocoagulation Treatment of Diabetic Macular Edema ; 5 % Versus 15 % Duty Cycle
Source: ClinicalTrials.gov · Last updated 5 Dec 2025
Brief summary (registry, in English)
To assess the safety and efficacy of 532 nm subthreshold micropulse laser 5 % duty cycle compared with 15 % duty cycle in treatment of diabetic macular edema .
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 24 Nov 2025
- Start date
- Nov 2025
- Primary completion date
- Nov 2026
- Lead sponsor
- Sohag University
- Diseases
- Diabetic eye disease
- NCT number
- NCT07266597
What you commit to
- Study type: Interventional
- Planned participants: 50
- From Nov 2025 to the primary completion date, Nov 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous lasered retina , Anti - VEGF injection or vitrectomy .
Age
- Associated ocular pathology as glaucoma, CNV (choroidal neovascularization ) , AMD (age related macular degenerations ), epiretinal membrane vitreomacular traction and retinal vein occlusion .
Other
- Extensive Macular ischemia on FFA .
- Media opacity .
Who the study is looking for
- Patients with diabetic retinopathy who:
- Are More than 18 years old .
- have diabetic macular edema with a central retinal thickness \< 400 um .
- have best corrected visual acuity between 6/18 and 6/60 .
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.